The USPTO’s Patent Trial and Appeal Board has ruled in favor of the Broad Institute of MIT and Harvard retaining intellectual property rights covered by its patents for CRISPR gene-editing technology.
May 1, 2013|
One, two, three, four . . . . Counting colonies and plaques can be tedious, but tools exist to streamline the process.